Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment?

Fig. 1

Study design: Group A started CPAP/NIV when P/F fell below 200, Group B underwent CPAP/NIV when P/F fell below 150. Group C derives from patients initially excluded from the study for refusal of non-invasive treatment and who subsequently initiated treatment with CPAP/NIV in a severe stage of ARDS (P/F ≤ 100). CPAP Continuous Positive Airway Pressure, NIV Non-Invasive Ventilation, P/F PaO2/FiO2 rate

Back to article page